Zydus Lifesciences' impactful campaign promotes self-breast examination for early detection of breast cancer, reaching ...

Fast Track Designation is given to drugs that are intended to treat serious conditions and or fill an unmet medical need.

Zydus Lifesciences announced that the U.S. Food and Drug Administration (USFDA) has granted Fast Track Designation to Usnoflast (ZYIL1), a novel oral NLRP3 inhibitor, for the treatment of Amyotrophic ...

The ‘Easiest Exam’ campaign promotes early detection of breast cancer, amassing over 164 million impressions and encouraging ...

Those with ALS have an average survival of around two to five years from diagnosis, with most ALS patients dying from ...

Zydus Lifesciences has received final approval from the USFDA to launch its isotretinoin capsules USP in six different ...

Nifty remains range-bound, potentially retesting lower supports unless it closes above 25050, while Bank Nifty's rising ...

Devan Choksey is bullish on Zydus Lifesciences has recommended buy rating on the stock with a target price of Rs 1069 in its research report dated May 26, 2025.

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, has announced that the USFDA has granted ‘Fast Track ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences’ ‘Easiest Exam’ Campaign a public health initiative in breast cancer awareness reaches millions: Our Bureau, Mumbai Monday, May 26, 2025, 15:15 Hrs [IST] ...